Indofarma Tbk (Indonesia) Performance
| INAF Stock | IDR 126.00 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Indofarma Tbk are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Indofarma Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Indofarma Tbk is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 158.2 B | |
| Total Cashflows From Investing Activities | -114.4 B |
Indofarma |
Indofarma Tbk Relative Risk vs. Return Landscape
If you would invest 12,600 in Indofarma Tbk on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Indofarma Tbk or generate 0.0% return on investment over 90 days. Indofarma Tbk is generating negative expected returns and assumes 0.0% volatility on return distribution over the 90 days horizon. Simply put, 0% of stocks are less volatile than Indofarma, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Indofarma Tbk Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Indofarma Tbk's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Indofarma Tbk, and traders can use it to determine the average amount a Indofarma Tbk's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| INAF |
Based on monthly moving average Indofarma Tbk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Indofarma Tbk by adding Indofarma Tbk to a well-diversified portfolio.
Indofarma Tbk Fundamentals Growth
Indofarma Stock prices reflect investors' perceptions of the future prospects and financial health of Indofarma Tbk, and Indofarma Tbk fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Indofarma Stock performance.
| Return On Equity | -0.59 | |||
| Return On Asset | -0.0451 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 3.17 T | |||
| Shares Outstanding | 3.1 B | |||
| Price To Book | 8.91 X | |||
| Price To Sales | 1.25 X | |||
| Revenue | 2.9 T | |||
| EBITDA | 70.22 B | |||
| Total Debt | 397.52 B | |||
| Book Value Per Share | 104.92 X | |||
| Cash Flow From Operations | 92.9 B | |||
| Earnings Per Share | (29.18) X | |||
| Total Asset | 2.01 T | |||
About Indofarma Tbk Performance
By examining Indofarma Tbk's fundamental ratios, stakeholders can obtain critical insights into Indofarma Tbk's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Indofarma Tbk is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Indofarma Tbk performance evaluation
Checking the ongoing alerts about Indofarma Tbk for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Indofarma Tbk help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Indofarma Tbk generated a negative expected return over the last 90 days | |
| The company reported the revenue of 2.9 T. Net Loss for the year was (37.58 B) with profit before overhead, payroll, taxes, and interest of 442.87 B. | |
| About 88.0% of the company shares are held by company insiders |
- Analyzing Indofarma Tbk's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Indofarma Tbk's stock is overvalued or undervalued compared to its peers.
- Examining Indofarma Tbk's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Indofarma Tbk's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Indofarma Tbk's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Indofarma Tbk's stock. These opinions can provide insight into Indofarma Tbk's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Indofarma Stock
Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.